Literature DB >> 25228774

Arginine deprivation and autophagic cell death in cancer.

Peter Wojciech Szlosarek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25228774      PMCID： PMC4191809          DOI： 10.1073/pnas.1416560111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  22 in total

Review 1.  Therapeutic targets in cancer cell metabolism and autophagy.

Authors:  Heesun Cheong; Chao Lu; Tullia Lindsten; Craig B Thompson
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

2.  Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis.

Authors:  Randie H Kim; Jodi M Coates; Tawnya L Bowles; Gregory P McNerney; Julie Sutcliffe; Jae U Jung; Regina Gandour-Edwards; Frank Y S Chuang; Richard J Bold; Hsing-Jien Kung
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

3.  Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia.

Authors:  K Morrow; C P Hernandez; P Raber; L Del Valle; A M Wilk; S Majumdar; D Wyczechowska; K Reiss; P C Rodriguez
Journal:  Leukemia       Date:  2012-08-28       Impact factor: 11.528

Review 4.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 5.  Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges.

Authors:  Melissa M Phillips; Michael T Sheaff; Peter W Szlosarek
Journal:  Cancer Res Treat       Date:  2013-12-31       Impact factor: 4.679

Review 6.  Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities.

Authors:  Rob A Cairns; Tak W Mak
Journal:  Cancer Discov       Date:  2013-06-24       Impact factor: 38.272

Review 7.  Autophagic cell death: the story of a misnomer.

Authors:  Guido Kroemer; Beth Levine
Journal:  Nat Rev Mol Cell Biol       Date:  2008-10-30       Impact factor: 94.444

8.  In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion.

Authors:  Peter W Szlosarek; Astero Klabatsa; Arben Pallaska; Michael Sheaff; Paul Smith; Tim Crook; Matthew J Grimshaw; Jeremy P Steele; Robin M Rudd; Frances R Balkwill; Dean A Fennell
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

9.  Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.

Authors:  N Syed; J Langer; K Janczar; P Singh; C Lo Nigro; L Lattanzio; H M Coley; E Hatzimichael; J Bomalaski; P Szlosarek; M Awad; K O'Neil; F Roncaroli; T Crook
Journal:  Cell Death Dis       Date:  2013-01-17       Impact factor: 8.469

10.  Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.

Authors:  Michael D Allen; Phuong Luong; Chantelle Hudson; Julius Leyton; Barbara Delage; Essam Ghazaly; Rosalind Cutts; Ming Yuan; Nelofer Syed; Cristiana Lo Nigro; Laura Lattanzio; Malgorzata Chmielewska-Kassassir; Ian Tomlinson; Rebecca Roylance; Hayley C Whitaker; Anne Y Warren; David Neal; Christian Frezza; Luis Beltran; Louise J Jones; Claude Chelala; Bor-Wen Wu; John S Bomalaski; Robert C Jackson; Yong-Jie Lu; Tim Crook; Nicholas R Lemoine; Stephen Mather; Julie Foster; Jane Sosabowski; Norbert Avril; Chien-Feng Li; Peter W Szlosarek
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701
View more
  14 in total

Review 1.  Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer.

Authors:  Alejandro Schcolnik-Cabrera; Daniel Juárez-López
Journal:  Cell Oncol (Dordr)       Date:  2022-08-29       Impact factor: 7.051

2.  Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.

Authors:  A W L Bayci; D A Baker; A E Somerset; O Turkoglu; Z Hothem; R E Callahan; R Mandal; B Han; T Bjorndahl; D Wishart; R Bahado-Singh; S F Graham; R Keidan
Journal:  Metabolomics       Date:  2018-08-03       Impact factor: 4.290

3.  Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20.

Authors:  Sounak Gupta; Divya Sahu; John S Bomalaski; Igor Frank; Stephen A Boorjian; Prabin Thapa; John C Cheville; Donna E Hansel
Journal:  Endocr Pathol       Date:  2018-09       Impact factor: 3.943

4.  A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas.

Authors:  Gregory R Bean; Jeff C Kremer; Bethany C Prudner; Aaron D Schenone; Juo-Chin Yao; Matthew B Schultze; David Y Chen; Munir R Tanas; Douglas R Adkins; John Bomalaski; Brian P Rubin; Loren S Michel; Brian A Van Tine
Journal:  Cell Death Dis       Date:  2016-10-13       Impact factor: 8.469

5.  A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor.

Authors:  Weitao Shen; Xuyao Zhang; Xiang Fu; Jiajun Fan; Jingyun Luan; Zhonglian Cao; Ping Yang; Zhongyuan Xu; Dianwen Ju
Journal:  Cell Death Dis       Date:  2017-03-30       Impact factor: 8.469

Review 6.  Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.

Authors:  Jiang Jiang; Hailong Li; Eskandar Qaed; Jing Zhang; Yushu Song; Rong Wu; Xinmiao Bu; Qinyan Wang; Zeyao Tang
Journal:  J Exp Clin Cancer Res       Date:  2018-02-13

Review 7.  Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy.

Authors:  Lifeng Xiong; Jade L L Teng; Michael G Botelho; Regina C Lo; Susanna K P Lau; Patrick C Y Woo
Journal:  Int J Mol Sci       Date:  2016-03-11       Impact factor: 5.923

8.  Inhibition of HDAC3- and HDAC6-Promoted Survivin Expression Plays an Important Role in SAHA-Induced Autophagy and Viability Reduction in Breast Cancer Cells.

Authors:  Jane Ying-Chieh Lee; Ching-Wen Kuo; Shing-Ling Tsai; Siao Muk Cheng; Shang-Hung Chen; Hsiu-Han Chan; Chun-Hui Lin; Kun-Yuan Lin; Chien-Feng Li; Jagat R Kanwar; Euphemia Y Leung; Carlos Chun Ho Cheung; Wei-Jan Huang; Yi-Ching Wang; Chun Hei Antonio Cheung
Journal:  Front Pharmacol       Date:  2016-03-31       Impact factor: 5.810

9.  Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia.

Authors:  Guro F Giskeødegård; Ailin Falkmo Hansen; Helena Bertilsson; Susana Villa Gonzalez; Kåre Andre Kristiansen; Per Bruheim; Svein A Mjøs; Anders Angelsen; Tone Frost Bathen; May-Britt Tessem
Journal:  Br J Cancer       Date:  2015-12-03       Impact factor: 7.640

10.  Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.

Authors:  Youngji Kim; Eisuke Kobayashi; Daisuke Kubota; Yoshiyuki Suehara; Kenta Mukaihara; Keisuke Akaike; Ayumu Ito; Kazuo Kaneko; Hirokazu Chuman; Akira Kawai; Shigehisa Kitano
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.